Breastfeeding lowers risk of MS relapse

accreditation
Breastfeeding may protect women with multiple sclerosis against relapses of their disease, possibly by delaying a return to normal monthly cycles, U.S. researchers reported on Monday.

They found that MS patients who nursed their babies exclusively - meaning no bottled formula - for at least 2 months appeared less likely to have a relapse within a year of the child's birth than women who did not breastfeed.

"It is well-known that women with MS have fewer relapses during pregnancy and a high risk of relapse in the postpartum period," the researchers wrote in the Archives of Neurology.

Women also are advised not to take MS drugs during pregnancy or while breastfeeding, so patients must choose between nursing their babies and resuming treatment. The American Academy of Pediatrics recommends breastfeeding exclusively for the first 6 months of a baby's life and continued nursing for at least a year.

Dr. Annette Langer-Gould, formerly of Stanford University School of Medicine in California and now of Kaiser Permanente Southern California in Pasadena, and her colleagues studied 32 pregnant women with MS and 29 pregnant women without MS.

Nearly all - 96% - of the healthy women breastfed their babies, as opposed to 69% of the MS patients.

They found that 87% of the women with MS who did not breastfeed, or who started using formula within 2 months, had a relapse, compared to 36% of those who gave their babies only breast milk for at least 2 months.

The women who breastfed exclusively delayed the return of normal menstruation, the researchers noted. Those whose monthly cycles stayed repressed, a normal effect of breastfeeding, were those whose MS symptoms did not return.

"Studies of immunity and breastfeeding, while plentiful, are predominantly focused on breast milk content and health benefits to the infant. Little is known about maternal immunity during breastfeeding," the researchers wrote.

Multiple sclerosis occurs when the immune system mistakenly attacks the fatty myelin sheath protecting nerve cells. It affects 2.5 million people globally - disproportionately women of childbearing age. It can cause mild illness in some people and permanent disability in others.

Symptoms may include numbness or weakness in the limbs, loss of vision and an unsteady gait.

Do you have MS? Have you experienced this?


We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
What are your thoughts on the possibility of having permanent Stage 2 or 3 load shedding?
Please select an option Oops! Something went wrong, please try again later.
Results
I'll take that over constant schedule changes
13% - 494 votes
Why are we normalising Eskom’s mess?
72% - 2737 votes
I've already found alternative ways of powering my home/business
15% - 551 votes
Vote
Rand - Dollar
17.20
-0.1%
Rand - Pound
21.27
+0.3%
Rand - Euro
18.72
+0.0%
Rand - Aus dollar
12.22
+0.0%
Rand - Yen
0.13
-0.3%
Platinum
1,014.13
+1.0%
Palladium
1,673.78
+0.4%
Gold
1,930.83
+0.1%
Silver
23.74
-0.7%
Brent Crude
87.47
+1.5%
Top 40
74,989
+0.7%
All Share
81,025
+0.6%
Resource 10
78,370
+0.2%
Industrial 25
104,053
+0.9%
Financial 15
16,304
+0.7%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE